Earnings Alerts

### Headline: Bangkok Dusit Medical Services (BDMS) Earnings: 2Q Net Income Aligns with Estimates at 3.33 Billion Baht

  • Bangkok Dusit’s net income for the second quarter is 3.33 billion baht.
  • The net income estimate was 3.36 billion baht, making the actual result very close to expectations.
  • Earnings per share (EPS) are reported as 0.21 baht.
  • The EPS estimate was 0.22 baht, also closely in line with the actual figure.
  • Analysts’ recommendations for Bangkok Dusit include 26 buys.
  • There are 2 hold recommendations for the stock.
  • No analysts have recommended selling Bangkok Dusit stock.

Bangkok Dusit Medical Services on Smartkarma

Analyst coverage of Bangkok Dusit Medical Services on Smartkarma highlights positive growth trends in the company. Tina Banerjee‘s research on BDMS TB indicates that in 1Q24, the company experienced double-digit revenue growth driven by both international and Thai patients, with a new cancer care center set to open in 3Q24. EBITDA and net profit also saw significant increases, surpassing estimates. The expansion of services, including a new hospital and upcoming cancer center, indicates a promising outlook for BDMS.

In another report by Tina Banerjee, BDMS’s 4Q23 results showcase continued strong performance, with double-digit growth fueled by international and Thai non-COVID patient revenues. The company’s outlook for 2024 remains positive, with expectations of sustained growth supported by favorable healthcare sector dynamics in Thailand. With consistent revenue growth and a focus on core business strengths, Bangkok Dusit Medical Services demonstrates resilience and potential for further expansion in the healthcare industry.


A look at Bangkok Dusit Medical Services Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth5
Resilience4
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts at Smartkarma have provided insights into the long-term outlook for Bangkok Dusit Medical Services. With a strong growth score of 5, the company is positioned for significant expansion in the future. This, coupled with solid resilience (score of 4) and momentum (score of 4), indicates a promising trajectory for the company moving forward.

Furthermore, while the value score is moderate at 2, the dividend score sits at a respectable 3. Overall, the company’s outlook appears positive, especially in terms of growth potential and the ability to weather challenges, making Bangkok Dusit Medical Services a noteworthy player in the healthcare sector.

### Summary ###
Bangkok Dusit Medical Services Public Company Limited operates Bangkok General Hospital, focusing on specialized medical services such as cardiovascular, lung, neurological, eye and genitourinary cancer treatments, as well as physical therapy and medical imaging.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars